ReviewLaboratory animal research2026
Advancing neurofibromatosis research: a comparative review of animal models and their utility in dissecting the tumor microenvironment.
Review in Laboratory animal research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurofibromatosis is a genetic disorder characterized by nervous system tumors arising primarily from NF1 or NF2 mutations. Given the complexity of the genetic background and heterogeneity of associated tumor phenotypes in neurofibromatosis, mechanistic investigations rely heavily on experimental animal models. Human tissue-based studies alone cannot fully elucidate causal relationships, temporal dynamics, modifier gene effects, or cell type-specific contributions to tumor development, progression, and microenvironmental regulation. Consequently, various animal models have been developed, including genetically engineered mouse models, large-animal systems, alternative vertebrate models, and transplantation-based approaches. These experimental platforms enable the controlled manipulation of gene dosage, lineage-specific gene deletion, immune modulation, targeted disruption of stromal and extracellular matrix components, and evaluation of therapeutic response and drug resistance mechanisms. Animal models have helped demonstrate the cell-autonomous and non-cell-autonomous mechanisms underlying neurofibromatosis tumorigenesis. Furthermore, sustained tumor maintenance and progression require coordinated interactions between neoplastic cells and their surrounding microenvironment. Notably, these experimental systems offer a temporal resolution not achievable in clinical specimens, demonstrating that microenvironmental alterations may precede overt tumor formation. Such findings depict the tumor microenvironment (TME) as an active contributor to disease rather than merely as a consequence of tumor growth. In this review, we evaluate the experimental scope, methodological strengths, and inherent limitations of current animal models used in neurofibromatosis research, with emphasis on their utility in elucidating interactions within the TME and non-neoplastic disease manifestations. This work characterizes model-specific advantages and constraints to emphasize the continued importance of animal models as essential tools for hypothesis-driven investigation and translational development in elucidating the various attributes of neurofibromatosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.